China Pharmaceutical Glass Packaging Market, By Material (Type I, Type II, Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials and Others), Drug Type (Generic, Branded, Biologic), Application (Oral, Injectable, Nasal, Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, Others), Market Trends and Forecast to 2028.
Market Analysis and Insights: China Pharmaceutical Glass Packaging Market
China pharmaceutical glass packaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 644,097.16 thousand by 2028.
It is increasing health awareness and adopting new techniques for storing liquid drugs that drive the market. The increasing cost of overall drug packaging acts as a restraint to the market. The growing demand for ready-to-use glass vials plays as an opportunity for pharmaceutical glass packaging manufacturing. The increasing stringent government regulations relating to pharmaceutical glass packaging can be a challenge for the manufacturers.
This pharmaceutical glass packaging market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
China Pharmaceutical Glass Packaging Market Scope and Market Size
The pharmaceutical glass packaging market is segmented based on material, product, drug type, application, and end-use. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of material, the market is segmented into Type I, Type II, and Type III. In China, Type I is dominating because of the growing usage in drug formulations storage methods, which has widened its consumption.
- On the basis of product, the market is segmented into bottles, ampoules, cartridges and syringes, vials, and others. In China, the bottles segment is dominating because of the increasing demand for airtight properties of products.
- On the basis of drug type, the market is segmented into generic, branded, and biologic. In China, generic is dominating because of growing usage among young and old age groups.
- On the basis of application, the market is segmented into nasal, oral, injectable, and others. In China, oral is dominating because of the increasing consumption of products among the end-users.
- On the basis of end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy, and others. In China, pharmaceutical companies are expected to dominate the market because of the increasing growth of the sector due to the ongoing pandemic situation.
Pharmaceutical Glass Packaging Market Country Level Analysis
The pharmaceutical glass packaging market is segmented based on material, product, drug type, application, and end-use.
China pharmaceutical glass packaging market is dominating the market due to the growing demand for packaging in the pharmaceutical industry in the region.
China Pharmaceutical Glass Packaging Market, By Drug Type
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of China brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Growth in the Pharmaceutical Glass Packaging Industry during the Pandemic
China pharmaceutical glass packaging market also provides you with detailed market analysis for every country growth in the installed base of different kinds of products for the pharmaceutical glass packaging market, impact of technology using lifeline curves and changes in infant formula regulatory scenarios, and their impact on the pharmaceutical glass packaging market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Pharmaceutical Glass Packaging Market Share Analysis
China pharmaceutical glass packaging market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to China pharmaceutical glass packaging market.
The major players covered in the report are NIPRO, Gerresheimer AG, SGD Pharma (a subsidiary of Saint-Gobain), Shandong Province Medicinal Glass Co., Ltd., Bormioli Pharma S.p.a., Taian Youlyy Industrial Co., Ltd., SCHOTT AG, FRIGOGLASS, among other players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
For instance,
- In 2020, Shandong Province Medicinal Glass Co., Ltd. was named the 3rd of the top 10 enterprises for the daily usage of the glass industry in the China Light industry. The update helped the company to increase the customer base, which generates revenue for the company
SKU-